Morel, O.; Granier, A.; Lochon, L.; Trimaille, A.; Bisson, A.; Marchandot, B.; Bernard, A.; Fauchier, L.
Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study. J. Clin. Med. 2025, 14, 7001.
https://doi.org/10.3390/jcm14197001
AMA Style
Morel O, Granier A, Lochon L, Trimaille A, Bisson A, Marchandot B, Bernard A, Fauchier L.
Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study. Journal of Clinical Medicine. 2025; 14(19):7001.
https://doi.org/10.3390/jcm14197001
Chicago/Turabian Style
Morel, Olivier, Amandine Granier, Lisa Lochon, Antonin Trimaille, Arnaud Bisson, Benjamin Marchandot, Anne Bernard, and Laurent Fauchier.
2025. "Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study" Journal of Clinical Medicine 14, no. 19: 7001.
https://doi.org/10.3390/jcm14197001
APA Style
Morel, O., Granier, A., Lochon, L., Trimaille, A., Bisson, A., Marchandot, B., Bernard, A., & Fauchier, L.
(2025). Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study. Journal of Clinical Medicine, 14(19), 7001.
https://doi.org/10.3390/jcm14197001
